Facebook icon Twitter icon Forward icon

Resources issued to help FreeStyle Libre formulary inclusion

A national group representing diabetes consultants in the UK has issued resources to help healthcare professionals to get FreeStyle Libre onto their formulary.

FreeStyle Libre became available on prescription across the UK from November 1, 2017, subject to local health economy approval, but fears of a “postcode lottery” have emerged.

In response, the Association of British Clinical Diabetologists (ABCD) has shared items to support the local adoption of the technology. 

Meanwhile, NHS England’s Regional Medicines Optimisation Committee (RMOC) has issued a position statement about FreeStyle Libre, with advice aimed at Area Prescribing Committees. To read more, click here.

New guidance issued to boost CGM technology use

Greater investment in trials and improved consistency of safety reports are among new recommendations issued to help continuous glucose monitoring (CGM) technologies achieve full potential.

The European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) have joined forces to release the document. To read more, click here

NHS England releases footcare videos to increase good practice

A series of videos to help people with diabetes and healthcare professionals increase their “knowledge and understanding” of the importance of good footcare have been released by NHS England.

The three videos were developed by NHS England in the West Midlands through its Cardiovascular (CVD) Clinical Network to enable people to take greater control of their condition. To read more, click here

Type 3c diabetes mistaken for type 2 says study

More than 97 per cent of people who have previously experienced pancreatic disease are misdiagnosed typically with type 2 diabetes, research has claimed.

According to a study published in Diabetes Care, they should have been been diagnosed with type 3c diabetes, which occurs as a result of pancreatic inflammation, abnormal growth of tissue on the organ or surgically removing part or all of the tissue, affecting the body’s ability to produce insulin. To read more, click here

Findings of global type 1 teenager study unveiled

A landmark study involving thousands of teenagers with type 1 diabetes has shown ACE inhibitors or statins do not significantly reduce the levels of albumin in the urine.

The four-year trial, entitled Adolescent Type 1 Diabetes cardio-renal Intervention Trial (AdDIT), was developed to understand more about the development of long-term complications in young people with the condition. To read more, click here.

Diabetes study day to ‘develop deeper understanding’

A diabetes study day for healthcare professionals working within a hospital or community setting will help them develop their understanding of the condition.

The CPD-accredited 2nd Bedford Diabetes Study Day will take place on Thursday, January 18,  2018 and has been approved by the Federation of the Royal Colleges of Physicians. To read more, click here